224 related articles for article (PubMed ID: 20123514)
1. [Sexual dysfunction after curietherapy and external radiotherapy of the prostate for localized prostate cancer].
Huyghe E; Bachaud JM; Achard JL; Bossi A; Droupy S;
Prog Urol; 2009 Dec; 19 Suppl 4():S173-6. PubMed ID: 20123514
[TBL] [Abstract][Full Text] [Related]
2. [Sexual dysfunctions after prostate cancer radiation therapy].
Droupy S
Cancer Radiother; 2010 Oct; 14(6-7):504-9. PubMed ID: 20728392
[TBL] [Abstract][Full Text] [Related]
3. [Orgasm after curietherapy with permanent iodine-125 radioimplants for localized prostate cancer].
Delaunay B; Delannes M; Salloum A; Delavierre D; Wagner F; Jonca F; Thoulouzan M; Plante P; Bachaud JM; Soulie M; Huyghe E
Prog Urol; 2011 Dec; 21(13):932-9. PubMed ID: 22118358
[TBL] [Abstract][Full Text] [Related]
4. Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment.
Akbal C; Tinay I; Simşek F; Turkeri LN
Int Urol Nephrol; 2008; 40(2):355-63. PubMed ID: 17960489
[TBL] [Abstract][Full Text] [Related]
5. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review.
van der Wielen GJ; Mulhall JP; Incrocci L
Radiother Oncol; 2007 Aug; 84(2):107-13. PubMed ID: 17707936
[TBL] [Abstract][Full Text] [Related]
6. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
Lehrer S; Cesaretti J; Stone NN; Stock RG
BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
[TBL] [Abstract][Full Text] [Related]
8. Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer.
Huyghe E; Delannes M; Wagner F; Delaunay B; Nohra J; Thoulouzan M; Shut-Yee JY; Plante P; Soulie M; Thonneau P; Bachaud JM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):126-32. PubMed ID: 19362236
[TBL] [Abstract][Full Text] [Related]
9. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.
Morton GC; Loblaw DA; Sankreacha R; Deabreu A; Zhang L; Mamedov A; Cheung P; Keller B; Danjoux C; Szumacher E; Thomas G
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):811-7. PubMed ID: 19836166
[TBL] [Abstract][Full Text] [Related]
10. Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.
Shemtov OM; Radomski SB; Crook J
Can J Urol; 2004 Dec; 11(6):2450-5. PubMed ID: 15636671
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations.
Ohebshalom M; Parker M; Guhring P; Mulhall JP
J Urol; 2005 Jul; 174(1):258-62; discussion 262. PubMed ID: 15947650
[TBL] [Abstract][Full Text] [Related]
12. Erectile function after brachytherapy with external beam radiation for prostate cancer.
Fujioka H; Ishimura T; Sakai Y; Fujii T; Jo Y; Takenaka A; Fujisawa M
Arch Androl; 2004; 50(4):295-301. PubMed ID: 15277008
[TBL] [Abstract][Full Text] [Related]
13. The dosimetry of brachytherapy-induced erectile dysfunction.
Merrick GS; Butler WM
Med Dosim; 2003; 28(4):271-4. PubMed ID: 14684193
[TBL] [Abstract][Full Text] [Related]
14. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
[TBL] [Abstract][Full Text] [Related]
15. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial.
van der Wielen GJ; Hoogeman MS; Dohle GR; van Putten WL; Incrocci L
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):795-800. PubMed ID: 18164862
[TBL] [Abstract][Full Text] [Related]
16. Defining sexual outcomes after treatment for localized prostate carcinoma.
Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
[TBL] [Abstract][Full Text] [Related]
17. Erectile function outcome reporting after clinically localized prostate cancer treatment.
Burnett AL; Aus G; Canby-Hagino ED; Cookson MS; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus S; Liebert M; Moul JW; Tangen C; Thrasher JB; Thompson I;
J Urol; 2007 Aug; 178(2):597-601. PubMed ID: 17570435
[TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
Selek U; Cheung R; Lii M; Allen P; Steadham RE; Vantreese TR; Little DJ; Rosen II; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1039-46. PubMed ID: 15234037
[TBL] [Abstract][Full Text] [Related]
19. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.
Miller DC; Wei JT; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin PW; Sanda MG
Urology; 2006 Jul; 68(1):166-71. PubMed ID: 16844457
[TBL] [Abstract][Full Text] [Related]
20. The effect on erectile function of 103palladium implantation for localized prostate cancer.
Ponholzer A; Oismüller R; Somay C; Büchler F; Maier U; Hawliczek R; Rauchenwald M; Madersbacher S
BJU Int; 2005 Apr; 95(6):847-50. PubMed ID: 15794796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
